Soleno Therapeutics Stock Market Value
| SLNO Stock | USD 52.71 3.13 5.61% |
| Symbol | Soleno |
Soleno Therapeutics Price To Book Ratio
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Soleno Therapeutics. If investors know Soleno will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Soleno Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.79) | Return On Assets (0.48) | Return On Equity (0.91) |
The market value of Soleno Therapeutics is measured differently than its book value, which is the value of Soleno that is recorded on the company's balance sheet. Investors also form their own opinion of Soleno Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Soleno Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Soleno Therapeutics' market value can be influenced by many factors that don't directly affect Soleno Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Soleno Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Soleno Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Soleno Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Soleno Therapeutics 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Soleno Therapeutics' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Soleno Therapeutics.
| 10/31/2024 |
| 11/30/2024 |
If you would invest 0.00 in Soleno Therapeutics on October 31, 2024 and sell it all today you would earn a total of 0.00 from holding Soleno Therapeutics or generate 0.0% return on investment in Soleno Therapeutics over 30 days. Soleno Therapeutics is related to or competes with Annexon, Bolt Biotherapeutics, Lyra Therapeutics, Pulmatrix, Capricor Therapeutics, Akari Therapeutics, and Bio Path. Soleno Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization ... More
Soleno Therapeutics Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Soleno Therapeutics' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Soleno Therapeutics upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 2.63 | |||
| Information Ratio | 0.0265 | |||
| Maximum Drawdown | 13.4 | |||
| Value At Risk | (4.22) | |||
| Potential Upside | 5.87 |
Soleno Therapeutics Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Soleno Therapeutics' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Soleno Therapeutics' standard deviation. In reality, there are many statistical measures that can use Soleno Therapeutics historical prices to predict the future Soleno Therapeutics' volatility.| Risk Adjusted Performance | 0.0625 | |||
| Jensen Alpha | 0.0689 | |||
| Total Risk Alpha | (0.30) | |||
| Sortino Ratio | 0.0305 | |||
| Treynor Ratio | 0.191 |
Soleno Therapeutics Backtested Returns
Soleno Therapeutics appears to be very steady, given 3 months investment horizon. Soleno Therapeutics owns Efficiency Ratio (i.e., Sharpe Ratio) of 0.0723, which indicates the firm had a 0.0723% return per unit of risk over the last 3 months. We have found twenty-nine technical indicators for Soleno Therapeutics, which you can use to evaluate the volatility of the company. Please review Soleno Therapeutics' Semi Deviation of 2.5, risk adjusted performance of 0.0625, and Coefficient Of Variation of 1389.11 to confirm if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Soleno Therapeutics holds a performance score of 5. The entity has a beta of 1.09, which indicates a somewhat significant risk relative to the market. Soleno Therapeutics returns are very sensitive to returns on the market. As the market goes up or down, Soleno Therapeutics is expected to follow. Please check Soleno Therapeutics' expected short fall, and the relationship between the maximum drawdown and rate of daily change , to make a quick decision on whether Soleno Therapeutics' existing price patterns will revert.
Auto-correlation | 0.86 |
Very good predictability
Soleno Therapeutics has very good predictability. Overlapping area represents the amount of predictability between Soleno Therapeutics time series from 31st of October 2024 to 15th of November 2024 and 15th of November 2024 to 30th of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Soleno Therapeutics price movement. The serial correlation of 0.86 indicates that approximately 86.0% of current Soleno Therapeutics price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.86 | |
| Spearman Rank Test | 0.3 | |
| Residual Average | 0.0 | |
| Price Variance | 6.06 |
Soleno Therapeutics lagged returns against current returns
Autocorrelation, which is Soleno Therapeutics stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Soleno Therapeutics' stock expected returns. We can calculate the autocorrelation of Soleno Therapeutics returns to help us make a trade decision. For example, suppose you find that Soleno Therapeutics has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Soleno Therapeutics regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Soleno Therapeutics stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Soleno Therapeutics stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Soleno Therapeutics stock over time.
Current vs Lagged Prices |
| Timeline |
Soleno Therapeutics Lagged Returns
When evaluating Soleno Therapeutics' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Soleno Therapeutics stock have on its future price. Soleno Therapeutics autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Soleno Therapeutics autocorrelation shows the relationship between Soleno Therapeutics stock current value and its past values and can show if there is a momentum factor associated with investing in Soleno Therapeutics.
Regressed Prices |
| Timeline |
Pair Trading with Soleno Therapeutics
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Soleno Therapeutics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Soleno Therapeutics will appreciate offsetting losses from the drop in the long position's value.Moving together with Soleno Stock
| 0.73 | ESPR | Esperion Therapeutics Buyout Trend | PairCorr |
| 0.72 | EWTX | Edgewise Therapeutics | PairCorr |
| 0.64 | BHC | Bausch Health Companies | PairCorr |
Moving against Soleno Stock
| 0.71 | TAK | Takeda Pharmaceutical | PairCorr |
| 0.7 | MRK | Merck Company Fiscal Year End 6th of February 2025 | PairCorr |
| 0.67 | HLN | Haleon plc | PairCorr |
| 0.65 | RDY | Dr Reddys Laboratories | PairCorr |
| 0.6 | ELAN | Elanco Animal Health | PairCorr |
The ability to find closely correlated positions to Soleno Therapeutics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Soleno Therapeutics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Soleno Therapeutics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Soleno Therapeutics to buy it.
The correlation of Soleno Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Soleno Therapeutics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Soleno Therapeutics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Soleno Therapeutics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Soleno Therapeutics Correlation, Soleno Therapeutics Volatility and Soleno Therapeutics Alpha and Beta module to complement your research on Soleno Therapeutics. To learn how to invest in Soleno Stock, please use our How to Invest in Soleno Therapeutics guide.You can also try the Stocks Directory module to find actively traded stocks across global markets.
Soleno Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.